AVANT GUARD trial meets expectations despite pause for safety modifications ...

A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced ...

A major international trial has found that pulsed-field catheter ablation offers superior outcomes to antiarrhythmic drugs ...

A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation nearly doubles the success rate of treating persistent atrial fibrillation compared with medication. One year after ...

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...

HEART PROCEDURE SUPERIOR TO DRUGS FOR COMMON ARRHYTHMIA A minimally invasive procedure that “rewires” ‌the heart may be a ...

Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...

In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...

Johnson & Johnson has initiated the PERSIGMA randomized controlled trial (RCT), one of the first randomized studies ...